The aim was to summarize pneumococcal disease burden data among adults in Southern
Europe and the potential impact of vaccines on epidemiology. Of 4779 identified studies …

Background Lymphopenia is a marker of poor prognosis in patients with community-
acquired pneumonia (CAP), yet its impact on outcomes in patients with CAP and sepsis …

Objectives The aim of this study was to evaluate the diagnostic utility of a novel test kit that
could theoretically detect all serogroups of Legionella pneumophila for diagnosing …

Rationale: Recommended initial empiric antimicrobial treatment covers the most common
bacterial pathogens; however, community-acquired pneumonia (CAP) may be caused by …

Objectives We aimed to describe the prevalence, risk factors and outcomes of Methicillin-
susceptible S. aureus (MSSA) community-acquired pneumonia (CAP) and compare them …

Introduction Whether the sensitivity of the BinaxNOW Streptococcus pneumoniae urinary
antigen test kit (BinaxNOW), adjusted by some variables including vital signs, laboratory …

Severe community‐acquired pneumonia (sCAP) early in life is a leading cause of morbidity,
mortality, and irreversible sequelae. Herein, we report the clinical, etiological, and …

Lefamulin was the first systemic pleuromutilin antibiotic approved for intravenous and oral
use in adults with community-acquired bacterial pneumonia based on two phase 3 trials …

Community-acquired pneumonia (CAP) refers to infectious inflammation of the lung
parenchyma developing outside of a hospital. CAP has quite a high mortality and morbidity …

Background Streptococcus pneumoniae infections cause morbidity and mortality worldwide.
A rapid, simple diagnostic method could reduce the time needed to introduce definitive …